The U.S. Food and Drug Administration has approved the nation’s first mRNA-based influenza vaccine for adults aged 50 and older, marking a major...
By 193cc Agency CouncilAugust 6, 2026Thomas Strüngmann, a name that resonates with success and foresight in the pharmaceutical and investment industries, is an influential figure whose achievements have...
By 193cc World's BillionairesDecember 19, 2024Andreas Strüngmann, a name that is synonymous with success in the pharmaceutical and technology industries, is one of Germany’s wealthiest and most influential...
By 193cc World's BillionairesDecember 19, 2024